Pharmacological Treatment Options for Cerebellar Ataxia
Treatment Approach Based on Etiology
- For drug-induced cerebellar syndrome, the causative drug should be discontinued immediately, according to the American Society of Clinical Oncology 1, 2, 3, 4
- The European Academy of Neurology recommends intravenous immunoglobulins or corticosteroids for idiopathic adult-onset opsoclonus-myoclonus syndrome 5, 6
- Glycine receptor antibody-associated conditions often respond well to immunotherapy, as suggested by the European Academy of Neurology 5, 6
- Treatment of the underlying malignancy is crucial for paraneoplastic cerebellar ataxia, according to the American College of Radiology 5, 7
Drug-Induced Cerebellar Ataxia
- Discontinuation of the offending agent is the primary intervention for drug-induced cerebellar ataxia, as recommended by the American Society of Clinical Oncology 1, 2, 3
- Correction of electrolyte imbalances is necessary if present, according to the American Society of Clinical Oncology 1
- Supportive care during the recovery period is essential, as suggested by the American Society of Clinical Oncology 4, 8